PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature

被引:25
作者
Muselaers, Stijn [1 ]
Erdem, Selcuk [2 ]
Bertolo, Riccardo [3 ]
Ingels, Alexandre [4 ]
Kara, Onder [5 ]
Pavan, Nicola [6 ]
Roussel, Eduard [7 ]
Pecoraro, Angela [8 ]
Marchioni, Michele [9 ]
Carbonara, Umberto [10 ]
Marandino, Laura [11 ]
Amparore, Daniele [8 ]
Campi, Riccardo [12 ]
机构
[1] Radboud Univ Nijmegen, Dept Urol, Med Ctr, NL-6525 GA Nijmegen, Netherlands
[2] Istanbul Univ, Fac Med, Dept Urol, Div Urol Oncol, TR-34452 Istanbul, Turkey
[3] San Carlo Di Nancy Hosp, Dept Urol, I-00165 Rome, Italy
[4] Univ Hosp Henri Mondor, AP HP, Dept Urol, F-94000 Creteil, France
[5] Kocaeli Univ, Sch Med, Dept Urol, TR-41001 Izmit, Turkey
[6] Univ Trieste, Dept Med Surg & Hlth Sci, Urol Clin, I-34127 Trieste, Italy
[7] Univ Hosp Leuven, Dept Urol, B-3000 Leuven, Belgium
[8] Univ Turin, San Luigi Gonzaga Hosp, Dept Urol, I-10124 Turin, Italy
[9] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, I-66100 Chieti, Italy
[10] Univ Bari, Dept Emergency & Organ Transplantat Urol Androl &, I-70121 Bari, Italy
[11] IRCCS Osped San Raffaele, Dept Med Oncol, I-20132 Milan, Italy
[12] Univ Florence, Careggi Hosp, Unit Urol Robot Surg & Renal Transplantat, I-50121 Florence, Italy
关键词
PSMA PET; CT; renal cell carcinoma; kidney cancer; imaging; MEMBRANE ANTIGEN; F-18-DCFPYL PET/CT; F-18-FDG PET/CT; TOMOGRAPHY; EXPRESSION; NEOVASCULATURE; RECURRENCE; TRACER; TUMORS;
D O I
10.3390/jcm11071829
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the vast majority of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging occurs in the field of prostate cancer, PSMA is also highly expressed on the cell surface of the microvasculature of several other solid tumors, including renal cell carcinoma (RCC). This makes it a potentially interesting imaging target for the staging and monitoring of RCC. The objective of this review is to provide an overview of the current evidence regarding the use of PSMA PET/Computed Tomography in RCC patients.
引用
收藏
页数:11
相关论文
共 38 条
[31]   Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT [J].
Rowe, Steven P. ;
Gorin, Michael A. ;
Hammers, Hans J. ;
Javadi, M. Som ;
Hawasli, Hazem ;
Szabo, Zsolt ;
Cho, Steve Y. ;
Pomper, Martin G. ;
Allaf, Mohamad E. .
ANNALS OF NUCLEAR MEDICINE, 2015, 29 (10) :877-882
[32]   Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma [J].
Sasikumar, Arun ;
Joy, Ajith ;
Nanabala, Raviteja ;
Unni, Madhavan ;
Padmanabhan, T. K. .
CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) :E517-E519
[33]   Diagnostic potential of PET/CT using a 68Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience [J].
Sawicki, Lino M. ;
Buchbender, Christian ;
Boos, Johannes ;
Giessing, Markus ;
Ermert, Johannes ;
Antke, Christina ;
Antoch, Gerald ;
Hautzel, Hubertus .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (01) :102-107
[34]   Utility of 68Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma [J].
Siva, Shankar ;
Callahan, Jason ;
Pryor, David ;
Martin, Jarad ;
Lawrentschuk, Nathan ;
Hofman, Michael S. .
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2017, 61 (03) :372-378
[35]   Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role [J].
Spatz, Sophia ;
Tolkach, Yuri ;
Jung, Klaus ;
Stephan, Carsten ;
Busch, Jonas ;
Ralla, Bernhard ;
Rabien, Anja ;
Feldmann, Georg ;
Brossart, Peter ;
Bundschuh, Ralph A. ;
Ahmadzadehfar, Hojjat ;
Essler, Markus ;
Toma, Marieta ;
Mueller, Stefan C. ;
Ellinger, Joerg ;
Hauser, Stefan ;
Kristiansen, Glen .
JOURNAL OF UROLOGY, 2018, 199 (02) :370-377
[36]   The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison [J].
Tariq, Arsalan ;
Kwok, Michael ;
Pearce, Adam ;
Rhee, Handoo ;
Kyle, Samuel ;
Marsh, Phillip ;
Raveenthiran, Sheliyan ;
Wong, David ;
McBean, Rhiannon ;
Westera, Jurjen ;
Dunglison, Nigel ;
Esler, Rachel ;
Navaratnam, Anojan ;
Yaxley, John W. ;
Thomas, Paul ;
Pattison, David A. ;
Roberts, Matthew J. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (02) :66.e1-66.e9
[37]   Diagnostic Performance of 68Gallium Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Staging the Prostate Cancer with Intermediate or High Risk Prior to Radical Prostatectomy: A Systematic Review and Meta-Analysis [J].
Wu, Hui ;
Xu, Ting ;
Wang, Xiao ;
Yu, Yong-Bo ;
Fan, Zhong-Yuan ;
Li, Dan-Xia ;
Luo, Lei ;
Yang, Xue-Cheng ;
Jiao, Wei ;
Niu, Hai-Tao .
WORLD JOURNAL OF MENS HEALTH, 2020, 38 (02) :208-219
[38]   Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [18F]DCFPyL PET/CT [J].
Yin, Yafu ;
Campbell, Scott P. ;
Markowski, Mark C. ;
Pierorazio, Philip M. ;
Pomper, Martin G. ;
Allaf, Mohamad E. ;
Rowe, Steven P. ;
Gorin, Michael A. .
MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (03) :567-573